A federal health agency is acknowledging that a sizable portion—between about 20 percent and 40 percent—of people being treated for cancer are using cannabis products to manage side effects from the condition and associated treatment. Such widespread uptake by patients raises concerns that use is outpacing scientific knowledge on efficacy and risks, the agency said […]